Pioneering trial tests stem cells in utero to fight devastating brittle bone disease
NCT ID NCT03706482
Summary
This early-stage trial is testing whether stem cells from a donor, given to infants before or after birth, are safe and can help treat severe osteogenesis imperfecta (brittle bone disease). The study involves up to 18 infants and compares them to children who did not receive this treatment. The main goals are to check for safety and see if the treatment reduces the number of bone fractures and improves bone density.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Stockholm, Stockholm County, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.